neo-angin® sugarfree throat lozenges
Product Characteristics
The formulation of neo-angin
® sugarfree throat lozenges may vary slightly in specific countries. Please contact us for further information.
1. Name of the productneo-angin
® sugarfree throat lozenges
2. Prescription status/available in pharmacies onlyavailable in pharmacies only
3. Composition of medicinal product3.1 Substance or indication grouporomucosal use
3.2 Active components according to type and quantity
one lozenge contains:
|
| 2,4-dichlorbenzyl alcohol |
1.20 mg |
| amylmetacresol |
0.60 mg |
| menthol |
5.72 mg |
3.3 Excipientsliquid maltitol, flavouring, colouring E124
4. Areas of applicationFor disinfection of the oral and pharyngeal cavities with sore throat, hoarseness, catarrh, colds, angina, inflammations of the oral and pharyngeal cavities as well as inflammations of the gums.
5. Contraindicationnot suitable for children under 6 years
6. Side effectsnone known
7. Interactions with other drugsnone known
8. Special warningsnone known
9. Most important incompatibilitiesnone known
10. Dosage with single and daily administrationUnless otherwise prescribed, adults and children over 6 years of age should allow one lozenge to dissolve slowly in the mouth every 2-3 hours
11. Method and duration of applicationoromucosal use, not limited
12. Emergency measures, symptoms and antidotesnone known
13. Pharmacological and toxicological properties, pharmacokinetics and bioavailablability to the extent that this information is required for therapeutic use
neo-angin
® sugarfree throat lozenges are effective against almost all gram-positive and gram-negative bacteria which occur in the oral and pharyngeal cavities as well as fungi and yeasts. The rapid bactericidal effect deserves special emphasis. In addition to the antiseptic effect, menthol has pain-alleviating and secretion-restricting effects on the mucosa.
Through the properties described above neo-angin
® combats and alleviates the symptoms of inflammatory catarrhal infections of the mouth and throat. It is well tolerated and has a pleasant flavour.
14. Other informationDiabetics should note that one lozenge corresponds to 0.22 BU. The sugar replacement substance, liquid maltitol (Lycasin
®), is broken down with the help of insulin.
15. Shelf life2 years
16. Special precautions for storageLycasin tablets are hygroscopic; that is, they draw moisture from the environment.
When storing for a longer time period, they should therefore be kept in a cool and dry place. The preparation must not be administered after the expiration date.
17. Presentation and pack sizepacks with 24 and 48 lozenges
18. Date of informationJanuary 1999
19. Name or company and address of the pharmaceutical enterpriseDivapharma-Knufinke
Arzneimittelwerk GmbH
Motzener Str. 41
12277 Berlin
Telephone (030) 72007-266
back